<HashMap><database>BioModels</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Xml>https://www.ebi.ac.uk/biomodels/model/download/MODEL1812040001?filename=Model.xml</Xml><Other>https://www.ebi.ac.uk/biomodels/model/download/MODEL1812040001?filename=V2.cps</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><submitter>Sarubini Kananathan</submitter><curationStatus>Non-curated</curationStatus><levelVersion>L2V4</levelVersion><full_dataset_link>https://www.ebi.ac.uk/biomodels/MODEL1812040001</full_dataset_link><publication_pubmed>24345497</publication_pubmed><isPrivate>false</isPrivate><repository>BioModels</repository><omics_type>Models</omics_type><modelFormat>SBML</modelFormat><tokenised_name>Bedessem2014   HiF 1 a  mediated response to hypoxia on the G1/S transition</tokenised_name><publication_year>2014</publication_year><submissionId>MODEL1812040001</submissionId><publication_authors>B Bedessem, Angélique Stéphanou</publication_authors><first_author>B Bedessem</first_author><publication>24345497,
                            Hypoxia is known to influence the cell cycle by increasing the G1 phase duration or by inducing a quiescent state (arrest of cell proliferation). This entry into quiescence is a mean for the cell to escape from hypoxia-induced apoptosis. It is suggested that some cancer cells have gain the advantage over normal cells to easily enter into quiescence when environmental conditions, such as oxygen pressure, are unfavorable [43,1]. This ability contributes in the appearance of highly resistant and aggressive tumor phenotypes [2]. The HiF-1α factor is the key actor of the intracellular hypoxia pathway. As tumor cells undergo chronic hypoxic conditions, HiF-1α is present in higher level in cancer than in normal cells. Besides, it was shown that genetic mutations promoting overstabilization of HiF-1α are a feature of various types of cancers [7]. Finally, it is suggested that the intracellular level of HiF-1α can be related to the aggressiveness of the tumors [53,24,4,10]. However, up to now, mathematical models describing the G1/S transition under hypoxia, did not take into account the HiF-1α factor in the hypoxia pathway. Therefore, we propose a mathematical model of the G1/S transition under hypoxia, which explicitly integrates the HiF-1α pathway. The model reproduces the slowing down of G1 phase under moderate hypoxia, and the entry into quiescence of proliferating cells under severe hypoxia. We show how the inhibition of cyclin D by HiF-1α can induce quiescence; this result provides a theoretical explanation to the experimental observations of Wen et al. (2010) [50]. Thus, our model confirms that hypoxia-induced chemoresistance can be linked, for a part, to the negative regulation of cyclin D by HiF-1α.. null, 248.
                            UJF-Grenoble 1, CNRS, Laboratory TIMC-IMAG/DyCTIM, UMR 5525, 38041 Grenoble, France. Electronic address: Baptiste.Bedessem@imag.fr.</publication><submitter_mail>skananathan@ebi.ac.uk</submitter_mail><submitter_affiliation>EMBL-EBI</submitter_affiliation><pubmed_abstract>Hypoxia is known to influence the cell cycle by increasing the G1 phase duration or by inducing a quiescent state (arrest of cell proliferation). This entry into quiescence is a mean for the cell to escape from hypoxia-induced apoptosis. It is suggested that some cancer cells have gain the advantage over normal cells to easily enter into quiescence when environmental conditions, such as oxygen pressure, are unfavorable [43,1]. This ability contributes in the appearance of highly resistant and aggressive tumor phenotypes [2]. The HiF-1α factor is the key actor of the intracellular hypoxia pathway. As tumor cells undergo chronic hypoxic conditions, HiF-1α is present in higher level in cancer than in normal cells. Besides, it was shown that genetic mutations promoting overstabilization of HiF-1α are a feature of various types of cancers [7]. Finally, it is suggested that the intracellular level of HiF-1α can be related to the aggressiveness of the tumors [53,24,4,10]. However, up to now, mathematical models describing the G1/S transition under hypoxia, did not take into account the HiF-1α factor in the hypoxia pathway. Therefore, we propose a mathematical model of the G1/S transition under hypoxia, which explicitly integrates the HiF-1α pathway. The model reproduces the slowing down of G1 phase under moderate hypoxia, and the entry into quiescence of proliferating cells under severe hypoxia. We show how the inhibition of cyclin D by HiF-1α can induce quiescence; this result provides a theoretical explanation to the experimental observations of Wen et al. (2010) [50]. Thus, our model confirms that hypoxia-induced chemoresistance can be linked, for a part, to the negative regulation of cyclin D by HiF-1α.</pubmed_abstract><pubmed_title>A mathematical model of HiF-1α-mediated response to hypoxia on the G1/S transition.</pubmed_title><pubmed_authors>Bedessem B B, Stéphanou A A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bedessem2014 - HiF-1 a -mediated response to hypoxia on the G1/S transition</name><description>No description</description><dates><last_modification>2018-12-04</last_modification><publication>2018-12-04</publication><submission>2018-12-04</submission></dates><accession>MODEL1812040001</accession><cross_references><pubmed>24345497</pubmed><biomodels__db>MODEL1812040001</biomodels__db></cross_references></HashMap>